Articles with public access mandates - Sarah ZoharLearn more
Not available anywhere: 3
A Bayesian hybrid adaptive randomisation design for clinical trials with survival outcomes
M Moatti, S Chevret, S Zohar, WF Rosenberger
Methods of Information in Medicine 55 (01), 4-13, 2016
Mandates: US National Institutes of Health
Interest in an original methodology to define the optimal dosage of interferon-alpha-2a in metastatic melanoma patients
S Zohar, J Medioni, C Lebbé, MF Avril, D Kerob, P Eftekhari, A Driheme, ...
Melanoma research 19 (6), 379-384, 2009
Mandates: National Institute of Health and Medical Research, France
Trial Designs for Rare Diseases and Small Samples in Oncology
RA Beckman, C Chen, M Posch, S Zohar
Textbook of Clinical Trials in Oncology, 297-315, 2019
Mandates: European Commission
Available somewhere: 23
Efficient adaptive designs for clinical trials of interventions for COVID-19
N Stallard, L Hampson, N Benda, W Brannath, T Burnett, T Friede, ...
Statistics in Biopharmaceutical Research 12 (4), 483-497, 2020
Mandates: UK Medical Research Council, National Institute for Health Research, UK …
Dose‐finding designs using a novel quasi‐continuous endpoint for multiple toxicities
M Ezzalfani, S Zohar, R Qin, SJ Mandrekar, MCL Deley
Statistics in medicine 32 (16), 2728-2746, 2013
Mandates: US National Institutes of Health
Phase I/II dose-finding design for molecularly targeted agent: plateau determination using adaptive randomization
MK Riviere, Y Yuan, JH Jourdan, F Dubois, S Zohar
Statistical methods in medical research 27 (2), 466-479, 2018
Mandates: US National Institutes of Health, National Institute of Health and Medical …
Does the low prevalence affect the sample size of interventional clinical trials of rare diseases? An analysis of data from the aggregate analysis of clinicaltrials. gov
SW Hee, A Willis, C Tudur Smith, S Day, F Miller, J Madan, M Posch, ...
Orphanet journal of rare diseases 12, 1-20, 2017
Mandates: UK Medical Research Council
Incorporating lower grade toxicity information into dose finding designs
A Iasonos, S Zohar, J O'Quigley
Clinical Trials 8 (4), 370-379, 2011
Mandates: US National Institutes of Health
A Bayesian dose finding design for clinical trials combining a cytotoxic agent with a molecularly targeted agent
MK Riviere, Y Yuan, F Dubois, S Zohar
Journal of the Royal Statistical Society Series C: Applied Statistics 64 (1 …, 2015
Mandates: US National Institutes of Health
Optimizing sedative dose in preterm infants undergoing treatment for respiratory distress syndrome
PF Thall, HQ Nguyen, S Zohar, P Maton
Journal of the American Statistical Association 109 (507), 931-943, 2014
Mandates: US National Institutes of Health
Quality assessment of phase I dose-finding cancer trials: proposal of a checklist
S Zohar, Q Lian, V Levy, K Cheung, A Ivanova, S Chevret
Clinical Trials 5 (5), 478-485, 2008
Mandates: US National Institutes of Health
The impact of non–drug-related toxicities on the estimation of the maximum tolerated dose in phase I trials
A Iasonos, M Gounder, DR Spriggs, JF Gerecitano, DM Hyman, S Zohar, ...
Clinical Cancer Research 18 (19), 5179-5187, 2012
Mandates: US National Institutes of Health
Dose-finding designs for cumulative toxicities using multiple constraints
SM Lee, M Ursino, YK Cheung, S Zohar
Biostatistics 20 (1), 17-29, 2019
Mandates: US National Institutes of Health
Personalized dynamic treatment regimes in continuous time: a Bayesian approach for optimizing clinical decisions with timing
W Hua, H Mei, S Zohar, M Giral, Y Xu
Bayesian Analysis 17 (3), 849-878, 2022
Mandates: US National Science Foundation
Bayesian treatment comparison using parametric mixture priors computed from elicited histograms
PF Thall, M Ursino, V Baudouin, C Alberti, S Zohar
Statistical methods in medical research 28 (2), 404-418, 2019
Mandates: US National Institutes of Health
Integration of elicited expert information via a power prior in Bayesian variable selection: Application to colon cancer data
S Boulet, M Ursino, P Thall, B Landi, C Lepère, S Pernot, A Burgun, ...
Statistical methods in medical research 29 (2), 541-567, 2020
Mandates: US National Institutes of Health
Value of information methods to design a clinical trial in a small population to optimise a health economic utility function
M Pearce, SW Hee, J Madan, M Posch, S Day, F Miller, S Zohar, ...
BMC medical research methodology 18, 1-9, 2018
Mandates: European Commission
dfpk: an R-package for Bayesian dose-finding designs using pharmacokinetics (PK) for phase I clinical trials
A Toumazi, E Comets, C Alberti, T Friede, F Lentz, N Stallard, S Zohar, ...
Computer Methods and Programs in Biomedicine 157, 163-177, 2018
Mandates: European Commission
Validity of biomarkers of early circulatory impairment to predict outcome: A retrospective analysis
MC Bravo, P López-Ortego, L Sánchez, R Madero, F Cabañas, A Koch, ...
Frontiers in Pediatrics 7, 212, 2019
Mandates: Government of Spain
Bayesian variable selection based on clinical relevance weights in small sample studies—Application to colon cancer
S Boulet, M Ursino, P Thall, AS Jannot, S Zohar
Statistics in Medicine 38 (12), 2228-2247, 2019
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program